bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.03.19.712863

Bacteriophage host prediction using a genome language model

Abstract

Computational bacteriophage host prediction from genomic sequences remains challenging because host range depends on diverse, rapidly evolving genomic determinants--from receptor-binding proteins to anti-defense systems and downstream infection compatibility--and because the signals available to predictors, including sequence homology, CRISPR spacer matches, nucleotide composition, and mobile genetic elements, are sparse, unevenly distributed across taxa, and constrained by incomplete host annotations. Here, we frame host prediction as an unsupervised retrieval problem. We asked whether embeddings from the pretrained genome language model Evo2 captured a reliable host-range signal without training on phage-host labels. We generated whole-genome embeddings for phages and candidate bacterial hosts with the Evo2-7B model, applied normalization, and ranked hosts by cosine similarity. Using the Virus-Host Database, we selected embedding and fusion choices on a Gram-positive validation cohort and then evaluated the approach on a held-out Gram-negative test cohort to minimize data leakage. We found that Evo2 was strongest at retrieving multiple plausible hosts, with the recorded host in the top 10 for 55.4% of phages. However, it did not maximize species-level top-1 accuracy (19.4% vs. 23.2% for the best baseline). At higher taxonomic ranks, Evo2 captured a coarser host-range signal: top-1 accuracy reached 43.4% at the genus level and 51.6% at the family level. Reciprocal rank fusion of Evo2 with BLASTN, VirHostMatcher, and PHIST improved all retrieval metrics. Top-10 retrieval rose to 58.5% and top-1 accuracy to 26.9%. Stratified analyses by phage genome length, host clade, and host mobile genetic element coverage revealed scenario-dependent performance. Evo2 embeddings excelled for intermediate-length phages and when host mobile element content was low, whereas alignment and k-mer methods dominated when local homology was abundant. These results suggest that pretrained genome embeddings complement established alignment- and k-mer/composition-based methods and that context-aware hybrid pipelines may help improve phage host prediction. Author summaryBacteriophages are viruses that prey on bacteria and play central roles in microbial ecosystems, nutrient cycling, and the spread of antibiotic resistance genes. Knowing which bacterium a phage can infect is important for applications such as phage therapy, where viruses are used to treat bacterial infections, but making this prediction from DNA sequence data alone remains difficult. Existing computational tools each exploit different types of genomic evidence, and none works reliably across all settings. We asked whether an artificial intelligence model trained to read raw DNA--without ever being shown which phages infect which hosts--could contribute a new, complementary signal. We found that this approach was particularly effective at narrowing the field to a short list of candidate hosts and at capturing broad evolutionary relationships between phages and bacteria. When we combined it with established sequence-comparison tools, overall prediction improved beyond what any single method achieved alone. By examining when each method succeeded or failed, we identified biological factors that govern prediction difficulty, offering practical guidance for building more robust prediction systems.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

WANG, Z., Arsuaga, J.. 2026-03-20. Bacteriophage host prediction using a genome language model. https://doi.org/10.64898/2026.03.19.712863

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Heterogeneous Graph Contrastive Learning for Drug-Gene-Disease Motif Prediction

Drug repurposing and target discovery offer critical strategies for advancing therapeutic development by uncovering the potential biological pathways and novel associations among drugs, genes, and diseases. However, experimental discovery remains expensive and time-consuming, which limits the scalability of large-scale studies. In addition, existing computational approaches often struggle to effectively integrate heterogeneous biomedical data, capture the complex higher-order topological signatures of biological interactomes, and generalize to unseen entities. Here, we present HANAMI (Heterogeneous grAph coNtrastive leArning for drug-gene-disease Motif predIction), a multi-view deep graph learning framework designed to model complex interactions among drugs, genes, and diseases. HANAMI integrates diverse heterogeneous biomedical knowledge, including chemical structures, genomic sequences, and clinical phenotypes, and leverages relation-aware topology encoding, structure-aware aggregation, and contrastive learning to enable accurate motif prediction with biological context from the network. Systematic evaluation on benchmark datasets shows that HANAMI achieves up to 6% improvements over existing state-of-the-art methods in predicting drug-gene-disease motifs. The framework further demonstrates strong inductive generalization, maintaining an [~]18% performance advantage in zero-shot settings involving previously unseen entities. Beyond predictive performance, HANAMI effectively prioritizes drug-disease relationships investigated in Phase II or III trials while identifying candidate genes that suggest plausible mechanistic links. Together, HANAMI provides a computational framework for interpreting complex biomedical interactions, offering a scalable foundation to accelerate drug repurposing and therapeutic innovation.

bioinformatics↗

PTMExplorer: A Multi-Dimensional Integrative Visualization Platform for Protein Post-Translational Modification Function and Structure

Deciphering the functions of post-translational modifications (PTMs) is a critical bridge connecting large-scale modification proteomics data to mechanistic studies. However, most existing tools for visualizing PTM omics data are limited to site catalogs or single-dimensional feature displays. They lack the capability to simultaneously map user-derived differential modification sites onto multi-dimensional contexts, including protein three-dimensional (3D) structure, evolutionary conservation, functional sites, and disease associations. This limitation makes it difficult for researchers to rapidly assess the biological importance of candidate sites from among a vast number of differentially modified sites. Here, we present PTMExplorer, an interactive platform for the multi-dimensional visualization of protein PTMs. PTMExplorer comprises three core modules: PTM Inspector, built upon ProtVista, provides a multi-track, sequence-feature integrated view incorporating intrinsically disordered region (IDR) prediction (via flDPnn), surface accessibility calculation (via FreeSASA), and UniProt functional annotations; PTM 3D Locator, leveraging the Nightingale/Mol* engine, anchors modification sites onto AlphaFold/Protein Data Bank (PDB) 3D structures through residue mapping via PDBe-SIFTS; and PTM Overview, utilizing the R circlize package, presents a panoramic polar circos plot illustrating modification distribution and inter-group differential regulation. Additionally, three major disease-associated modification databases (PTMD, qPTM, and PhosCancer) are integrated as PTM-Disease Nexus, enabling co-localization comparison between user-defined differential sites and reported disease-related sites. PTMExplorer currently supports eight model organisms, accepts user-uploaded differential analysis results, and provides multi-dimensional annotations and various visualization options (https://www.bioladder.cn/PTMExplorer/). Using a multi-omics dataset from hepatocellular carcinoma (18 patients, 9 modification types) as a case study, we demonstrate the practical utility of PTMExplorer in screening potential biomarkers, revealing multi-modification coordination mechanisms, and distinguishing between absolute and relative quantification patterns.

bioinformatics↗

Integrative analysis of the MDM2 promoter switch and cellular lineage plasticity in colorectal cancer: a contrast between the autonomous-proliferation type (CIN/CMS2) and the environment-adaptive type (MSI/gastric metaplasia)

Background: Biomarkers that stratify colorectal cancer (CRC) by therapeutic responsiveness and are measurable directly in biopsy specimens remain insufficiently established. We investigated whether usage of the dual MDM2 promoters (P1/P2) acts as a molecular switch separating two diametrically opposed CRC phenotypes: a chromosomal instability type and an environment adaptive type (microsatellite instability/serrated pathway with gastric metaplasia). Methods: Sixty three organoid samples from 22 patients with CRC were classified morphologically by deep learning (VGG16) and molecularly by an MDM2 Splicing Index derived from expression arrays. The P1 and P2 signatures (gene sets characterizing P1 and P2dominant samples) were externally validated in TCGA-COAD/READ (n = 624) and GSE39582 (n = 536), 1,160 cases in total, and therapeutic implications were tested in public cell line panels (GDSC2, DepMap) and in 65 lines of an independent patient derived CRC organoid biobank. Results: Deep learning morphological classification reached 98.5% test accuracy (64/65), and morphology corresponded to P1/P2 isoform usage: Type1 (compact glandular) morphology predominated in P1 dominant samples (median Type1 fraction 0.826 versus 0.444) and non Type1 (cystic mucinous) morphology in P2 dominant samples (AUC 0.79). Both signatures differed across the four consensus molecular subtypes , and the P2 signature was higher in mismatch repair deficient (microsatellite-unstable) tumors. Promoter usage quantified directly (P2_index) was higher in TP53 wild type tumors , consistent with P2 being p53-inducible. TP53 wild type cell lines were more sensitive to the MDM2 inhibitor Nutlin 3a and were more dependent on MDM2 in the DepMap CRISPR screen ; among 198 GDSC2 drugs, Nutlin 3a correlated most strongly with the P2 score. In the independent biobank, TP53 wild type lines (17) were more sensitive to nutlin-3 than mutant lines (48) (median log(IC50) 1.386 versus 4.283). Conclusions: MDM2 promoter choice (P1/P2) co-varies with the lineage identity of cancer cells and with the secretory, mucin rich character of the tumor tissue, consistent with a molecular-switch role alongside p53 suppression. The MDM2 P1/P2 ratio, measurable by RT qPCR or targeted NGS, is a candidate molecular-classification and therapeutic-stratification biomarker corresponding robustly to CMS, MSI, and TP53 mutation status.

bioinformatics↗